PEPTIDES A-Z: USE TO FIRST CYCLE
This is the guide we wish existed when we started. A complete walkthrough from understanding what a peptide is to safely completing your first cycle — no assumed knowledge, no jargon left unexplained.
1.What a peptide actually is
Peptides are short chains of amino acids — the same building blocks that make up proteins, but in smaller, more targeted sequences. Your body already produces thousands of peptides naturally, and they serve as signaling molecules: telling your pituitary gland to release growth hormone, triggering tissue repair cascades, modulating appetite, regulating immune function, and far more.
When you buy a research peptide, you are buying a synthesized version of one of these naturally occurring signaling molecules. The intent is to amplify or mimic a signal your body already uses — not to introduce something entirely foreign. This is why the safety profile of most peptides differs fundamentally from anabolic steroids, which work by directly binding androgen receptors and overriding the body's natural hormonal balance.
Peptides are classified by their amino acid count. Dipeptides have two amino acids, tripeptides have three, and so on. Most research peptides fall in the range of 2 to 50 amino acids. Below 2 amino acids is just an amino acid. Above 50 amino acids begins the territory of small proteins. BPC-157, for reference, is a 15-amino acid peptide.
The body's own peptide production declines with age. GH-releasing hormones, thymic peptides, and protective gut peptides all decrease over time. This is the underlying rationale for exogenous peptide use as part of an aging or recovery protocol — restoring signals that have declined rather than introducing wholly new pharmacological interventions.
Not every amino acid chain you swallow becomes a working peptide. Digestion is specifically designed to break down amino acid chains, which is why nearly all effective peptides must be injected subcutaneously. Oral bioavailability is minimal for anything larger than a very short peptide, with a few notable exceptions like certain gut-localized applications of BPC-157.
2.Where to source and what to look for
In the United States, most peptides are sold as 'research chemicals' — meaning they can be legally purchased and possessed but cannot be sold for human consumption. Reputable suppliers publish a certificate of analysis (CoA) for every product, tested by an independent third-party HPLC laboratory. If a vendor does not publish CoAs from named external labs, move on immediately.
Look for purity above 98% on HPLC testing. Mass spectrometry (MS) confirmation of the correct molecular weight adds another verification layer — it confirms you have the right compound, not just a pure unknown substance. Avoid vendors who only test in-house. Third-party testing is the minimum credibility bar in this space.
Community vetting matters. The peptide vendor landscape changes rapidly — vendors improve and decline in quality, go out of business, or get acquired. Reddit's r/Peptides is the most active community for current vendor reputation, with running threads that aggregate user testing data, anonymized lab reports, and firsthand accounts. Look for patterns across many users over time, not single reviews.
Pricing is not a reliable quality indicator above a certain floor. Extremely cheap peptides (dramatically below market) are a red flag — quality synthesis is not free. But the most expensive vendor is not automatically the best. Focus on documentation quality, community reputation, and response to batch testing results from independent community members.
Batch consistency is something experienced users check over multiple orders. A single clean CoA is good. Three consecutive batches from the same vendor all testing above 99% purity on independent community testing is much better evidence of a reliable operation.
The practical first step: identify 2-3 vendors with strong, sustained community reputations. Order a single compound from one of them. Run it, assess quality based on expected effects, and then make further sourcing decisions. Do not try to optimize sourcing perfectly before you have personal experience with any vendor.
3.Storage before and after reconstitution
Lyophilized (freeze-dried) peptide powder is stable at room temperature for weeks, refrigerated at 2-8°C for 12+ months, and frozen at -20°C for 2 years or more. Once you have opened the vial by piercing the rubber stopper, keep it refrigerated and minimize exposure to heat, light, and humidity.
After reconstitution with bacteriostatic water (BAC water), most peptides are stable in the refrigerator for 4-6 weeks. Some peptides degrade faster — GLP-1 analogs and more fragile peptides like Epithalon have shorter reconstituted shelf lives. Mark the reconstitution date on the vial with a marker or label tape.
BAC water is the correct reconstitution liquid for nearly all research peptides. It contains 0.9% benzyl alcohol, which prevents bacterial contamination in multi-use vials over the weeks you are drawing from them. Sterile water lacks this preservative and should only be used when you plan to use the entire vial within 24-72 hours.
Store reconstituted vials upright, not on their side. Keep them away from the refrigerator door, where temperature swings with every opening. Never freeze a reconstituted vial — ice crystal formation physically damages the peptide's three-dimensional structure in ways that cannot be reversed when thawed.
Light exposure degrades peptides gradually. Some users wrap reconstituted vials in aluminum foil or store them in the original cardboard box to limit UV exposure. This is a good practice, especially for compounds you are using over a 4-6 week period.
4.Reconstitution: the exact process
Gather your supplies before starting: the peptide vial, BAC water vial, insulin syringe(s), alcohol swabs, and a clean flat surface. Wash your hands thoroughly. Wipe the rubber stopper of both vials with a fresh alcohol swab and allow them to air dry for 30 seconds before piercing.
Draw the desired amount of BAC water into your insulin syringe. The amount depends on your desired concentration — see the reconstitution calculator for exact numbers. A common choice for a 5mg peptide vial is 1-2mL of BAC water, giving concentrations of 5000 mcg/mL or 2500 mcg/mL respectively.
Insert the needle into the peptide vial at an angle so the tip points toward the inner glass wall. Let the BAC water run down the glass slowly rather than squirting it directly onto the peptide powder. Direct force on the powder can degrade it. The powder will gradually dissolve as the water reaches it.
After adding all the BAC water, gently swirl the vial between your palms or roll it in a slow circle. Do not shake it — shaking causes foaming and can denature the peptide. Some peptides (TB-500 in particular) take 2-5 minutes to fully dissolve. Be patient; the solution should become completely clear before you use it.
Your reconstituted vial is now ready. The first draw from it will set the concentration for all future doses from that vial — accuracy at this step matters. Use the PepVault calculator to verify your concentration and dose volume before injecting.
5.Your first injection: step by step
Choose your injection site. For most people starting out, the lower abdomen (avoiding the 2-inch area directly around the navel) is the most accessible and comfortable subcutaneous site. Pinch the skin slightly to lift the fat layer away from the muscle beneath.
Wipe the injection site with an alcohol swab. Critically: let it dry completely before injecting. Injecting through wet alcohol causes a sharp burning sensation that has nothing to do with the peptide itself — it is entirely avoidable.
Draw your dose into the insulin syringe. Confirm the volume matches what you calculated. Hold the syringe like a pencil, insert the needle at a 45-degree angle in one smooth motion. For very lean individuals, 90 degrees may be needed to ensure the injection is subcutaneous rather than intramuscular.
Depress the plunger slowly and steadily. Remove the needle, apply light pressure with a clean swab for 10-15 seconds. You do not need to rub — just gentle pressure. If there is a small bruise, that is normal and inconsequential.
Cap the needle and dispose of it in a sharps container (a puncture-resistant container, not the regular trash). Used insulin syringes should never be reused — the needle tip dulls after a single use, making subsequent injections more painful. Do not recap by holding the cap in your hand; place it on a flat surface and scoop the cap onto the needle.
Log the injection: date, compound, dose, site. This takes 60 seconds and produces data you will thank yourself for later when assessing results over weeks.
6.What to expect in the first two weeks
Most peptides are not dramatic in the first week. Resist the urge to judge effectiveness immediately. The physiological changes that peptides produce accumulate over weeks to months, not hours to days.
GH secretagogues (ipamorelin, GHRP-2, CJC-1295 no DAC) typically produce the earliest noticeable effects: improved sleep depth and vivid dreams within the first week, and a mild hunger spike in the 30-60 minutes after injection. These are signs the peptides are active and working as expected.
BPC-157 users often report acute changes in pain and inflammation within 3-7 days for fresh injuries. For chronic injuries, the timeline is longer — meaningful improvement typically takes 2-4 weeks. For gut health applications, many users notice reduced bloating and improved digestion within the first 2 weeks.
GLP-1 agonists like semaglutide begin suppressing appetite within the first 3-5 days. GI side effects (nausea, bloating) are most common in this first week. This is a normal adaptation response and typically improves substantially by week 4.
Do not increase your dose because you do not feel dramatic effects in week one. Peptide protocols are measured in weeks, not days. Running the protocol consistently for 8-12 weeks before making judgments is the standard that produces reliable data about whether a compound is working for you.
Sources & Studies
Hoberman JM. et al., Curr Sports Med Rep, 2012
Sigalos JT, Pastuszak AW., Sex Med Rev, 2018
Muttenthaler M. et al., Nat Rev Drug Discov, 2021